Dermatomyositis: Muscle Pathology According to Antibody Subtypes

Area of Science:

• Immunodermatology
• Neuromuscular Pathology
• Autoimmune Diseases

Background:

• Dermatomyositis-specific antibodies (DMSAs) are linked to varied myopathologic features.
• Perifascicular atrophy and MxA overexpression are key diagnostic criteria for dermatomyositis.
• Understanding subtype-specific pathology aids in classifying dermatomyositis.

Purpose of the Study:

• To investigate myopathologic features in MxA-positive dermatomyositis.
• To identify characteristic muscle pathology in different DMSA subtypes.
• To establish a comprehensive serologic-pathologic correlation in dermatomyositis.

Main Methods:

• Retrospective review of muscle biopsies from 2009-2020.
• Inclusion of MxA-positive and DMSA-seropositive or seronegative cases.
• Histochemical, immunohistochemical, and ultrastructural analyses of muscle tissue.

Main Results:

• 256 patients included: 249 DMSA-seropositive and 7 seronegative.
• Distinct features identified: anti-TIF1-γ (vacuolated fibers), anti-Mi-2 (fiber damage, inflammation), anti-MDA5 (diffuse MxA), anti-NXP-2 (microinfarction), anti-SAE/seronegative (HLA-DR).
• Significant correlations found between DMSA subtypes and specific histopathologic findings (p < 0.05).

Conclusions:

• DMSAs are associated with distinct myopathologic features in dermatomyositis.
• These features suggest different underlying pathobiologic mechanisms for each DMSA subtype.
• MxA expression serves as a valuable inclusion criterion for serologic-pathologic correlation.